Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

30%

3 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2

2(28.6%)

N/A

2(28.6%)

Phase 3

2(28.6%)

Phase 4

1(14.3%)

7Total

Phase 2(2)

N/A(2)

Phase 3(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT02212015Phase 2Terminated

Evaluation of Votrient in Angiosarcoma

Role: collaborator

NCT02577692Not ApplicableUnknown

Inspired Oxygen on Oxidative Stress and Breath Volatile Organic Compound Composition in Healthy Volunteers

Role: lead

NCT01077427Phase 3Unknown

Hyperthermia European Adjuvant Trial

Role: lead

NCT01449344Phase 3Unknown

Efficacy and Safety of R-HAD Alone or in Combination With Bortezomib in Patients With Relapsed or Refractory MCL

Role: collaborator

NCT02310607Completed

Non-invasive Optical Detection of Iron Deficiency

Role: lead

NCT00832234Phase 2Completed

Bortezomib, Dexamethasone, and Rituximab in Untreated Waldenstroms Macroglobulinemia

Role: collaborator

NCT01935297Not ApplicableCompleted

Exercise Training After Transcatheter Aortic Valve Implantation

Role: collaborator

NCT01363856Unknown

Center for Stroke Research Berlin (CSB) Prospective Stroke Cohort

Role: collaborator

NCT00831688Phase 4Completed

Efficacy of Local Overpressure Treatment for Meniere's Disease

Role: lead

NCT00650650Completed

Comparison of Ultrasound Versus Radiography for Diagnosis of Nasal Fractures

Role: lead

All 10 trials loaded